In a new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Dr Brigham Hyde, co-founder and CEO of Atropos Health, and Ardy Arianpour, co-founder and CEO of SEQSTER, about
Earlier this year, Bayer formed a new business unit that promised to shake up the consumer health category with a new personalised approach driven by digital technologies.
Health systems are being squeezed by ageing populations, overstretched health professionals, unsustainable costs and a failure to tackle disease prevention – and a new way
In July 2013, pharmaphorum filmed a round table debate, sponsored by AstraZeneca, to discuss the topic of 'Oncology shaping the future of personalised healthcare'.
Consumer DNA testing company 23andMe has signed a deal to acquire privately-held Lemonaid Health in a $400 million deal that marks a move into the online health sector.
An alarming number of people in England are being prescribed medicines unnecessarily, which could harm their health, according to a UK government review.
Owlstone Medical has secured a $5 million equity investment and initial $1.5 million grant funding, committed by the Bill and Melinda Gates Foundation, for development of
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.